Dr. Michael Chen, CEO & Co-founder of GBB, will present “Progress of AI-Driven Site-Specific Integration Cell Line Development for IND Submission and Developability Assessment” at the Cell Line Development & Engineering session.

 · March 9–11, 2026
· San Diego Convention Center
· Cell Line Development & Engineering

Great Bay Bio will showcase how our AI-driven platforms accelerate CMC processes, from early discovery to high-efficiency cell line development. Our intelligent ecosystem helps shorten timelines, enhance product quality, and improve overall development predictability.

Join us to explore how GBB is making global bioprocessing simpler and more efficient.

See you in San Diego!

#GreatBayBio #GBB #BPI #BPIWest2026 #bioprocessing #CMC #biotech